Insider NameBuy/SellCompany NameTickerAmountShares Change
May 23, 2025May 28, 2025Katkin Keith
Dir
SellEmergent Biosolutions Inc.EBS$6.3$49,417-8.32%
May 19, 2025May 19, 2025Katkin Keith
Dir
BuySyndax Pharmaceuticals IncSNDX$9.11$91,120+9.09%
Oct 06, 2022Oct 07, 2022Katkin Keith
Dir
SellSyndax Pharmaceuticals IncSNDX$25.9$774,411-48.30%
Sep 30, 2022Oct 04, 2022Katkin Keith
Dir
SellSyndax Pharmaceuticals IncSNDX$25.06$102,777-11.36%
Dec 09, 2019Dec 11, 2019Katkin Keith
PEO;CEO
Urovant Sciences
Inc
SellUrovant Sciences Ltd.UROV$12.78$2M-0
Dec 15, 2014Dec 18, 2014Katkin Keith
Pres
CEO
SellAvanir Pharmaceuticals, Inc.AVNR$16.95$5M-23.30%
Oct 24, 2014Oct 25, 2014Katkin Keith
Pres
CEO
SellAvanir Pharmaceuticals, Inc.AVNR$11.76$324,188-3.63%
Aug 01, 2014Aug 02, 2014Katkin Keith
Pres
CEO
SellAvanir Pharmaceuticals, Inc.AVNR$5.26$50,864-1.26%
May 28, 2014May 31, 2014Katkin Keith
Pres
CEO
SellAvanir Pharmaceuticals, Inc.AVNR$5.01$2M-37.09%
Dec 18, 2013Dec 20, 2013Katkin Keith
Pres
CEO
SellAvanir Pharmaceuticals, Inc.AVNR$2.67$78,935-6.21%
Nov 01, 2013Nov 06, 2013Katkin Keith
Pres
CEO
SellAvanir Pharmaceuticals, Inc.AVNR$4.14$18,138-0.91%
Aug 02, 2013Aug 02, 2013Katkin Keith
Pres
CEO
SellAvanir Pharmaceuticals, Inc.AVNR$4.84$74,981-3.13%
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.